Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zimmer Biomet Inc.

    NYSE: ZBH · Real-Time Price · USD
    100.15
    1.03 (1.04%)
    At close: Sep 17, 2025, 9:45 AM
    1.04%
    Bid 100.05
    Market Cap 19.84B
    Revenue (ttm) 7.83B
    Net Income (ttm) 823.4M
    EPS (ttm) 4.1
    PE Ratio (ttm) 24.43
    Forward PE 11.78
    Analyst Hold
    Dividends $1.2
    Ask 100.21
    Volume 118,581
    Avg. Volume (20D) 1,738,009
    Open 99.45
    Previous Close 99.12
    Day's Range 99.14 - 101.59
    52-Week Range 89.22 - 114.72
    Beta 0.68
    Ex-Dividend Date Sep 30, 2025

    About zbh

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol zbh
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for zbh stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Zimmer Biomet Inc. is scheduled to release its earnings on Oct 29, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    +7.99%
    Zimmer Biomet Holdings shares are trading higher a... Unlock content with Pro Subscription
    4 months ago
    -11.62%
    Zimmer Biomet Holdings shares are trading lower after the company lowered its FY25 guidance.
    news image

    1 day ago · zacks.com

    Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term

    The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

    news image

    4 days ago · zacks.com

    ZBH or ESLOY: Which Is the Better Value Stock Right Now?

    Investors interested in stocks from the Medical - Products sector have probably already heard of Zimmer Biomet (ZBH) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks present...

    news image

    1 week ago · seekingalpha.com

    Zimmer Biomet Holdings, Inc. (ZBH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

    Zimmer Biomet Holdings, Inc. (NYSE:ZBH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 8:30 AM EDT Company Participants Ivan Tornos - President, CEO & Chairman of the Board...

    news image

    2 weeks ago · zacks.com

    Should You Add Zimmer Biomet Stock to Your Portfolio Now?

    ZBH rides on knee innovation and robotics growth, but debt and macro pressures challenge its upside potential.

    news image

    2 weeks ago · zacks.com

    ZBH vs. ESLOY: Which Stock Is the Better Value Option?

    Investors interested in stocks from the Medical - Products sector have probably already heard of Zimmer Biomet (ZBH) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks offers ...

    news image

    4 weeks ago · zacks.com

    Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock

    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

    1 month ago · youtube.com

    4 Stocks to Buy From a Top-Performing Fund Manager

    Bill Nygren's Oakmark Fund recently took new positions in these undervalued stocks.

    news image

    1 month ago · fool.com

    Got $1,000? 3 Dividend Stocks to Buy and Hold Forever

    Right now is not a good time in the healthcare sector. Various companies across the space are well below highs while the broader stock market chugs along at all-time highs.

    news image

    1 month ago · seekingalpha.com

    Zimmer Biomet Holdings, Inc. (ZBH) Q2 2025 Earnings Call Transcript

    Zimmer Biomet Holdings, Inc. (ZBH) Q2 2025 Earnings Call Transcript

    news image

    1 month ago · benzinga.com

    Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook

    Zimmer Biomet Holdings, Inc. ZBH reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99.

    Add to Watchlist